OBJECTIVE: Mesenchymal stem cells (MSC) have both self-renewal and multilineage differentiation potential, and bone marrow-derived MSC have been applied for tissue regeneration and repair. Although adipose tissue-derived MSC (ASC) have emerged as an alternative cell source, little information is available regarding the biologic difference between ASC derived from visceral and subcutaneous fat. Therefore, we aimed to compare the proliferation and gene expression profile of cultured human visceral ASC (VASC) and subcutaneous ASC (SASC), and to identify a novel gene involved in proliferation and differentiation of ASC. MATERIALS AND METHODS: We performed microarray analysis of cultured VASC and SASC, and investigated the role of tazarotene-induced gene 1 (TIG1), a most differentially expressed gene, in the proliferation and differentiation of ASC. RESULTS: SASC proliferated faster than VASC for over 10 passages, and TIG1 expression was consistently up-regulated in VASC of humans, rats and mice. Overexpression of the TIG1 gene in human SASC inhibited cell proliferation, whereas knockdown of TIG1 expression by siRNA promoted cell proliferation. In addition, overexpression of the TIG1 gene in SASC enhanced their differentiation into adipocytes, and promoted up-regulation of peroxisome proliferators-activated receptor gamma and CCAAT/enhancer binding protein alpha. On the other hand, TIG1 overexpression in SASC inhibited their differentiation into osteocytes and the expression of osteocalcin. CONCLUSION: TIG1 plays an important role in regulating proliferation and differentiation of ASC.
OBJECTIVE: Mesenchymal stem cells (MSC) have both self-renewal and multilineage differentiation potential, and bone marrow-derived MSC have been applied for tissue regeneration and repair. Although adipose tissue-derived MSC (ASC) have emerged as an alternative cell source, little information is available regarding the biologic difference between ASC derived from visceral and subcutaneous fat. Therefore, we aimed to compare the proliferation and gene expression profile of cultured human visceral ASC (VASC) and subcutaneous ASC (SASC), and to identify a novel gene involved in proliferation and differentiation of ASC. MATERIALS AND METHODS: We performed microarray analysis of cultured VASC and SASC, and investigated the role of tazarotene-induced gene 1 (TIG1), a most differentially expressed gene, in the proliferation and differentiation of ASC. RESULTS: SASC proliferated faster than VASC for over 10 passages, and TIG1 expression was consistently up-regulated in VASC of humans, rats and mice. Overexpression of the TIG1 gene in human SASC inhibited cell proliferation, whereas knockdown of TIG1 expression by siRNA promoted cell proliferation. In addition, overexpression of the TIG1 gene in SASC enhanced their differentiation into adipocytes, and promoted up-regulation of peroxisome proliferators-activated receptor gamma and CCAAT/enhancer binding protein alpha. On the other hand, TIG1 overexpression in SASC inhibited their differentiation into osteocytes and the expression of osteocalcin. CONCLUSION:TIG1 plays an important role in regulating proliferation and differentiation of ASC.
Authors: Tamara Tchkonia; Marc Lenburg; Thomas Thomou; Nino Giorgadze; Garrett Frampton; Tamar Pirtskhalava; Andrew Cartwright; Mark Cartwright; John Flanagan; Iordanes Karagiannides; Norman Gerry; R Armour Forse; Yourka Tchoukalova; Michael D Jensen; Charalabos Pothoulakis; James L Kirkland Journal: Am J Physiol Endocrinol Metab Date: 2006-09-19 Impact factor: 4.310
Authors: M F Pittenger; A M Mackay; S C Beck; R K Jaiswal; R Douglas; J D Mosca; M A Moorman; D W Simonetti; S Craig; D R Marshak Journal: Science Date: 1999-04-02 Impact factor: 47.728
Authors: Lisa G Horvath; Jayne E Lelliott; James G Kench; C-Soon Lee; Elizabeth D Williams; Darren N Saunders; John J Grygiel; Robert L Sutherland; Susan M Henshall Journal: Prostate Date: 2007-07-01 Impact factor: 4.104
Authors: Zhengang Peng; Rulong Shen; Ying-Wei Li; Kun-Yu Teng; Charles L Shapiro; Huey-Jen L Lin Journal: PLoS One Date: 2012-05-17 Impact factor: 3.240
Authors: Wenbo Ma; Bart Tummers; Edith M G van Esch; Renske Goedemans; Cornelis J M Melief; Craig Meyers; Judith M Boer; Sjoerd H van der Burg Journal: Front Immunol Date: 2016-11-22 Impact factor: 7.561
Authors: E E Oldridge; H F Walker; M J Stower; M S Simms; V M Mann; A T Collins; D Pellacani; N J Maitland Journal: Oncogenesis Date: 2013-04-15 Impact factor: 7.485
Authors: Mark G Lebwohl; Emil A Tanghetti; Linda Stein Gold; James Q Del Rosso; Nelly K Gilyadov; Abby Jacobson Journal: Dermatol Ther (Heidelb) Date: 2021-06-09